Cancer is essentially a disease of the cell replication cycle. The goal of treating the disease is to permanently kill off the cells that replicate with abandon without any molecular brakes. Chemotherapy and radiation cause breaks in DNA, and eventually, death even in these out-of-control cells. Within minutes after being exposed to treatment, cancer cells call on DNA-repair proteins to counteract the damage wrought by these treatments. Days later, immune cells show up to tumors to assist further in beating back cells that have survived the effects of the toxic therapies.
This delayed arrival of immune cells after cancer therapy is well documented and critical for responses to chemotherapy and radiation, yet the events underlying their induction remain poorly understood. Now, researchers have discovered how DNA damage is a clarion call for the immune system. The findings are published in Nature.
"Having solved what cues immune cells to arrive at cancer cells with DNA damage in the first place, we can apply that information to design better treatments," said senior author. "This tactic aims to improve a patient's response to treatment using the immune system at the same time as inhibitors to keep cancer cells on track to replicate until cell death sets in."
If a cell's DNA is damaged, it stalls for about 24 hours at a point in the cell replication cycle just prior to entering a phase that leads to cell division. Cells resume dividing as they eventually overcome their wounds, and this leads to activation of signals that attracts the immune system.
In the Nature study, the team describes how DNA damage from cancer therapies causes small packages of DNA from the nucleus to form in the cytoplasm when cells divide after experiencing DNA damage from radiation or chemotherapies. These out-of-place micronuclei tend to rupture, exposing DNA within the cytoplasm to a special surveillance protein. This watchdog molecule is typically activated when invaders such as viruses are detected as foreign DNA in the cytoplasm. The anti-microbe alarm incites an immune response, hailing immune cells to attack micronuclei-filled cancer cells.
The team demonstrated that inhibiting cells from progressing to later cell-division stages prevented micronuclei from forming and strongly reduced immune responses to cancer cells that had been treated with radiation.
Overall, the Nature study reveals that changes in how fast or slow a cancer cell progresses through cell division is an important consideration for cancer therapies that combine DNA damage and immune checkpoint inhibitors.
"Our work allows for the development of rational strategies to increase immune response to enhance patients' sensitivity to radiation," senior author said. "This approach would combine drugs that damage DNA and inhibit immune checkpoints with those that promote cell division by interfering with the factors that delay cell division in response to DNA damage."
https://www.pennmedicine.org/news/news-releases/2017/july/how-dna-damage-turns-immune-cells-against-cancer
http://www.nature.com/nature/journal/vaop/ncurrent/full/nature23470.html?foxtrotcallback=true
How DNA damage turns immune cells against cancer
- 1,425 views
- Added
Edited
Latest News
Protein that helps COVID-19…
By newseditor
Posted 26 Jul
Spinal Muscular Atrophy (SM…
By newseditor
Posted 26 Jul
Link between bowel movement…
By newseditor
Posted 26 Jul
Inhibition of IL-11 signall…
By newseditor
Posted 25 Jul
Brain changes linked to obe…
By newseditor
Posted 25 Jul
Other Top Stories
How to keep metabolites on the level
Read more
Modified extracellular vesicle signaling in ciliopathies
Read more
How a transcription factor might play a role in glioblastoma and au…
Read more
A new compound provides pain relief
Read more
Long non-coding RNAs as prognostic biomarkers in cancer
Read more
Protocols
A systems biology approach…
By newseditor
Posted 24 Jul
quantms: a cloud-based pipe…
By newseditor
Posted 22 Jul
Emerging tools and best pra…
By newseditor
Posted 19 Jul
Directly selecting cell-typ…
By newseditor
Posted 17 Jul
PUFFFIN: an ultra-bright, c…
By newseditor
Posted 16 Jul
Publications
Hepatocyte-intrinsic SMN de…
By newseditor
Posted 26 Jul
Aberrant bowel movement fre…
By newseditor
Posted 26 Jul
A pseudoautosomal glycosyla…
By newseditor
Posted 26 Jul
Microglia protect against a…
By newseditor
Posted 26 Jul
Rigor and reproducibility i…
By newseditor
Posted 26 Jul
Presentations
Myelin plasticity in the ve…
By newseditor
Posted 10 Jun
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar